Table 6. Univariate Cox proportional hazards regression analysis for CV events.
| Variables | HR (95% CI) | P |
|---|---|---|
| Age (years) | 1.026 (1.007–1.046) | 0.008 |
| Sex (male) | 0.989 (0.583–1.676) | 0.966 |
| Dialysis modality (HD) | 1.983 (0.890–4.418) | 0.094 |
| Smoking (Yes) | 0.871 (0.426–1.781) | 0.705 |
| DM | 1.771 (1.001–3.131) | 0.049 |
| Coronary arterial disease | 2.951 (1.599–5.446) | 0.001 |
| Arrhythmia | 3.524 (1.591–7.802) | 0.002 |
| Cerebrovascular disease | 2.782 (1.598–4.844) | <0.001 |
| Hemoglobin (g/dL) | 1.015 (0.992–1.038) | 0.205 |
| Serum albumin (g/dL) | 0.525 (0.334–0.825) | 0.005 |
| NT-proBNP (pg/mL) | 1.000 (1.000–1.001) | 0.002 |
| cTnT (ng/mL) | 2.174 (0.861–5.489) | 0.100 |
| 24-hr urine volume (mL/day) | 0.999 (0.998–1.000) | 0.001 |
| LVEF (%) | 0.948 (0.917–0.981) | 0.002 |
| LVEDD (mm) | 1.020 (0.985–1.057) | 0.263 |
| LVESD (mm) | 1.013 (0.910–1.127) | 0.813 |
| LVMI (g/m2) | 1.006 (0.999–1.013) | 0.104 |
| E/E’ | 1.068 (1.040–1.097) | <0.001 |
| E’ (cm/sec) | 0.839 (0.709–0.993) | 0.041 |
| E/A | 0.899 (0.654–1.431) | 0.654 |
| DT (msec) | 0.996 (0.991–1.000) | 0.059 |
| LAD (mm) | 1.860 (1.466–2.360) | <0.001 |
| LAVI (mL/m2) | 1.019 (1.011–1.028) | <0.001 |
| E/E’ >15 | 5.954 (3.253–10.900) | <0.001 |
| LAD >45 (mm) | 2.286 (1.351–3.867) | 0.002 |
| LAVI >32 (mL/m2) | 6.243 (2.676–14.563) | <0.001 |
CV, cardiovascular; HD, hemodialysis; DM, diabetes mellitus; NT-proBNP, N-terminal pro B-type natriuretic peptide; cTnT, cardiac troponin T; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end diastolic diameter; LVESD, left ventricular end systolic diameter; LVMI, left ventricular mass index; LAD, left atrial diameter; LAVI, left atrial volume index; DT, deceleration time